statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aquestive Therapeutics (NASDAQ:AQST - Get Free Report)s stock had its "buy" rating reiterated by research analysts at HC Wainwright in a report released on Friday, Benzinga reports. They...

Aquestive Therapeutics (NASDAQ:AQST) Earns "Buy" Rating from HC Wainwright

Aquestive Therapeutics (AQST) has provided an update. Aquestive Therapeutics, Inc. has bolstered its Board of Directors with the addition of Abigai...

Aquestive Therapeutics Welcomes Abigail Jenkins to Board

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aquestive Therapeutics appoints Jenkins to board of directors

Appoints Abigail Abbey Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of DirectorsWARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE...

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

Raymond James initiated coverage on shares of Aquestive Therapeutics (NASDAQ:AQST - Free Report) in a research report report published on Thursday, MarketBeat Ratings reports. The firm issued an...

Aquestive Therapeutics (NASDAQ:AQST) Research Coverage Started at Raymond James

Analysts at Raymond James initiated coverage on shares of Aquestive Therapeutics (NASDAQ:AQST - Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat reports...

Aquestive Therapeutics (NASDAQ:AQST) Coverage Initiated at Raymond James

WARREN, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ( Aquestive or the Company ), a pharmaceutical company advancing medicines to bring meaningful...

Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

This is a signal that AQST's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Aquestive Therapeutics (AQST, $4.51) Stochastic Oscillator left the overbought zone on March 20, 2024

This is a Bearish indicator signaling AQST's price could decline from here. Traders may explore shorting the stock or put options...

Aquestive Therapeutics (AQST, $4.51) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 20, 2024

This indicator may be signaling that AQST's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Aquestive Therapeutics (AQST, $4.51) entered Downtrend as Momentum indicator drops below 0 level on Mar 20, 2024

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Volume	5,609.00
52-Wk High	$6.23
52-Wk Low	$1.25

AQST Aquestive Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals